Compass Minerals International, Inc., provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertilizer solutions under the Protassium+ brand name; turf products used by the turf and ornamental markets, as well as for blends used on golf course greens; organic products; and develops and produces a portfolio of magnesium chloride-based aerial and ground fire retardant products. This segment provides its products to distributors and retailers of crop inputs, as well as growers. The company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003. Compass Minerals International, Inc. was founded in 1844 and is headquartered in Overland Park, Kansas.

Compass Minerals International, Inc.

Compass Pathways Plc ($CMPS) announced an update on their ongoing clinical study. The Redefine Study is a late-stage trial run by COMPASS Pathways ...

Compass Pathways Advances Redefine PTSD Trial, Keeping Psychedelic Therapy Hopes Alive

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS P...

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

In a report released today, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on COMPASS Pathways, with a price target of $21.00. Accor...

COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on COMPASS Pathways (CMPS) and Trulieve Cannabis (TRLV)...

Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and ICU Medical (ICUI) w...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and Halozyme (HALO) with...

Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX) and Halozyme (HALO)

Compass Minerals International ( ($CMP) ) has shared an update. Compass Minerals announced that Chief Operations Officer Patrick Merrin departed th...

Compass Minerals Names Brandon Risner New Chief Operating Officer

Analysts have been eager to weigh in on the Healthcare sector with new ratings on COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA). COMPASS ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CMP	$25.32	+0.72%	362.37K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CMP	$25.32	+0.7%	362.37K
3
4
5
6

CMP

Get Compass Minerals International, Inc. Data in Excel

Get Compass Minerals International, Inc. Data in Excel